Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration - Alvarez, Jessica A.; Chong, Elizabeth Y.; Walker, Douglas I.; Chandler, Joshua D.; Michalski, Ellen S.; Grossmann, Ruth E.; Uppal, Karan; Li, Shuzhao; Frediani, Jennifer K.; Tirouvanziam, Rabindra; Tran, ViLinh T.; Tangpricha, Vin; et al. (Metabolism, clinical and experimental, 2017)
Keywords: Cholecalciferol; Cystic fibrosis; Endocrinology & Metabolism; Metabolomics; Pulmonary exacerbation; Vitamin D; FEV1%predicted; Metabolomics; HRM; CF; Cholecalciferol; HCA; Cystic fibrosis; Human Metabolomics Database; PCA; TCA; Vitamin D; FDR; LIMMA; 25(OH)D; NIST SRM; Pulmonary exacerbation; BMI; hierarchical cluster analysis; amino acids; pulmonary exacerbation; metabolomics; cystic fibrosis; cholecalciferol; false discovery rate; National Institute of Standards and Technology Standard Reference Material; HMDB; percentage of predicted forced expiratory volume in 1 s; tricarboxylic acid; 25-hydroxyvitamin D; vitamin D; body mass index; linear models for microarray data; high-resolution metabolomics; principal component analysis